
Overview
Dr. Karantanos graduated from the School of Health Sciences at the University of Athens, Greece and received a Ph.D. in cancer biology. He completed a post-doctoral research fellowship in molecular oncology and cancer therapeutics at MD Anderson Cancer Center/University of Texas. He did his internal medicine residency and Chief residency training at Boston University and his medical oncology fellowship training at Johns Hopkins. As a research fellow at Johns Hopkins he studied malignant hematopoiesis and his work led to the identification of CCRL2, as an inducer of MDS/sAML cells growth and a mediator of azacitidine resistance.
Dr. Karantanos is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Acute Erythroid Leukemia (AEL), Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Karantanos is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 96 peer reviewed articles. Dr. Karantanos is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Stoler Outpatient Cancer Clinic
Maria Baer is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Baer is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Splenectomy. Dr. Baer is board certified in American Board Of Internal Medicine - Hematology, 1984 and American Board Of Internal Medicine - Internal Medicine, 1983. Dr. Baer is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therapeutic approaches for these diseases. She is nationally and internationally recognized expert in clinical translation of novel therapeutics for acute leukemias and principal investigator on multiple multi-center investigator-initiated studies. Dr. Gojo joined the Johns Hopkins faculty in 2012 as the Co-Director of Leukemia Drug Development Program. She has served on the National Cancer Institute (NCI) Investigational Drug Steering Committee since 2014. Dr. Gojo received a Service Star Award from Johns Hopkins Medicine Service Excellence in 2018 for her exemplary care of leukemia patients. Dr. Gojo contributed to the clinical translational and drug development effort of multiple novel agents targeting pathogenic pathways in patients with acute leukemia. Her research efforts are now concentrated on the development and integration of novel immunotherapies into therapeutic armamentarium for patients with acute leukemia. She mentors basic and clinical research fellows and junior faculty on the development and design of novel clinical trials and mechanistic laboratory studies associated with these trials. She served as a leukemia team leader on the National Institute of Health (NIH)/NCI N01 grant (Phase II consortium) (2009-2011), and is co-principal investigator (PI) on the Experimental Therapeutics (ET)-Clinical Trial Network (CTN) UM1 grant supporting early clinical trials. Dr. Gojo has served on the National Comprehensive Cancer Network guideline panel for AML since 2019, Myeloid Growth Factor guideline panel since 2015 and previously served on the MPNs guideline panel (2016-2019). She has extensive experience in the regulatory aspects of drug development and served as the Chair (2015-2016) and Co-Chair (2014-2015) of the Cancer Research Review Committee at Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, and serves as a member of the SKCCC Biostatistics Core Advisory Committee and SKCCC Clinical Research Office Coordinating Center Oversight Committee. Dr. Gojo is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gojo is board certified in American Board Of Internal Medicine. Dr. Gojo is currently accepting new patients.
Stoler Outpatient Cancer Clinic
Aaron Rapoport is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Rapoport is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Multiple Myeloma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Rapoport is board certified in American Board Of Internal Medicine - Internal Medicine, 1989 and American Board Of Internal Medicine - Hematology, 1992. Dr. Rapoport is currently accepting new patients.
Frequently Asked Questions about Dr. Theodoros Karantanos
How do I make an appointment with Dr. Theodoros Karantanos?
You can book an appointment with Dr. Theodoros Karantanos by calling their office at 410-955-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Theodoros Karantanos a top-rated expert for Acute Erythroid Leukemia (AEL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Theodoros Karantanos is classified as an Advanced expert for Acute Erythroid Leukemia (AEL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Theodoros Karantanos specialize in?
While Dr. Theodoros Karantanos is a Transplant Surgery, they have specific expertise in Acute Erythroid Leukemia (AEL), Myelodysplastic Syndrome (MDS), and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.
Does Dr. Theodoros Karantanos participate in research or clinical trials?
Yes. Dr. Theodoros Karantanos has published 96 articles and abstracts on conditions like Acute Erythroid Leukemia (AEL). You can view a list of Dr. Theodoros Karantanos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Theodoros Karantanos accept my insurance?
Dr. Theodoros Karantanos accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Erythroid Leukemia (AEL)Dr. Karantanos isAdvanced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Myeloid Leukemia (AML)Dr. Karantanos isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaDr. Karantanos isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Karantanos isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- SplenomegalyDr. Karantanos isAdvanced. Learn about Splenomegaly.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Karantanos isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Karantanos isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Karantanos isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Aplastic AnemiaDr. Karantanos isExperienced. Learn about Aplastic Anemia.
- Blood ClotsDr. Karantanos isExperienced. Learn about Blood Clots.
- Bone Marrow AspirationDr. Karantanos isExperienced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Karantanos isExperienced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Karantanos isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Karantanos isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Myelomonocytic Leukemia (CMML)Dr. Karantanos isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Essential ThrombocythemiaDr. Karantanos isExperienced. Learn about Essential Thrombocythemia.
- Graft Versus Host Disease (GvHD)Dr. Karantanos isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Hodgkin LymphomaDr. Karantanos isExperienced. Learn about Hodgkin Lymphoma.
- MyelofibrosisDr. Karantanos isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Dr. Karantanos isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Polycythemia VeraDr. Karantanos isExperienced. Learn about Polycythemia Vera.
- Prostate CancerDr. Karantanos isExperienced. Learn about Prostate Cancer.
- SplenectomyDr. Karantanos isExperienced. Learn about Splenectomy.
